...

CCO Official Conference Coverage

2008 International AIDS Conference

August 3-8, 2008 | Mexico City, Mexico

Timing and Choice of First-Line Antiretroviral Therapy

Track 1 of 6

Faculty:

Joel E. Gallant, MD, MPHJosé Gatell, MDW. David Hardy, MD
  • Joel E. Gallant, MD, MPH
  • José Gatell, MD
  • W. David Hardy, MD

Management of Treatment-Experienced Patients

Track 2 of 6

Faculty:

Joseph J. Eron, Jr., MDKimberly Y. Smith, MD, MPHAndrew R. Zolopa, MD
  • Joseph J. Eron, Jr., MD
  • Kimberly Y. Smith, MD, MPH
  • Andrew R. Zolopa, MD

Clinical Complications of HIV and Its Therapy

Track 3 of 6

Faculty:

Andrew Carr, MBBS, MD, FRACPDonald P. Kotler, MDBruce Polsky, MD
  • Andrew Carr, MBBS, MD, FRACP
  • Donald P. Kotler, MD
  • Bruce Polsky, MD

HIV Management in Women

Track 4 of 6

Faculty:

Judith S. Currier, MD, MScSally Hodder, MDKathleen E. Squires, MD
  • Judith S. Currier, MD, MSc
  • Sally Hodder, MD
  • Kathleen E. Squires, MD

Treatment and Biomedical Prevention in Resource-Limited Settings

Track 5 of 6

Faculty:

Richard E. Chaisson, MDElly Katabira, MDMauro Schechter, MD, PhD
  • Richard E. Chaisson, MD
  • Elly Katabira, MD
  • Mauro Schechter, MD, PhD

Highlights of the 2008 International AIDS Conference

Track 6 of 6

CCO Slideset

Highlights of IAC 2008

Download the Slideset


This downloadable slideset reviews the most clinically relevant new data on HIV/AIDS presented at the 2008 International AIDS Conference.


Format: Microsoft PowerPoint (.ppt) | File size: 2.40 MB | Date posted: 8/22/2008


Expert Highlights



Expert Highlight: Late Breaker Sessions

Daniel R. Kuritzkes, MD, highlights clinically relevant data from key studies presented at the 2008 International AIDS Conference Late Breaker Sessions (13 minutes)


Audio File 11.5 MB

Windows Video 18.2 MB

Quicktime Video 48.4 MB

iPod Video 145 MB

Partnership Information


Clinical Care Options is the official provider of online scientific conference coverage from AIDS 2008.  For more information about the meeting go to http://www.aids2008.org



This coverage is produced in association with the American Academy of HIV Medicine.  http://www.aahivm.org
Kaisernetwork.org, a free online health news and information service operated by the Kaiser Family Foundation, provides daily coverage of the conference including webcasts, transcripts and slide presentations of select sessions and press conferences, English- and Spanish-language audio podcasts of select sessions, interviews with newsmakers, news summaries from international media covering conference developments, and a free daily update email sent during the conference.  Sign up for the email and access the coverage at http://kaisernetwork.org/aids2008.
www.aidsmap.com provides comprehensive news coverage of the 2008 International AIDS Conference in Mexico City, with news reports each day and a daily summary email bulletin for those who just want the highlights of the meeting.
To view the daily news coverage, and to sign up for the daily highlights bulletin (also available in French, Spanish, Portuguese and Russian) go to http://www.aidsmap.com/mexico.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.

Capsule Summary:

Novel NNRTI RDEA806 Demonstrates Antiviral Activity Without Significant Adverse Events in 7-Day Monotherapy Study

Once-daily dosing of RDEA806 800 mg resulted in nearly 2 log10 decrease in median HIV-1 RNA by Day 8 in phase IIa dosing study; no evidence of rash or nervous system toxicity

CLICK HERE TO KEEP READING

CLICK HERE FOR RELATED CAPSULE SUMMARIES